Mauro David J 4
4 · Codiak BioSciences, Inc. · Filed May 4, 2022
Insider Transaction Report
Form 4
Mauro David J
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-05-02+200,000→ 200,000 totalExercise: $3.26Exp: 2032-05-01→ Common Stock (200,000 underlying) - Award
Restricted Stock Units
2022-05-02+20,000→ 20,000 total→ Common Stock (20,000 underlying)
Footnotes (3)
- [F1]25% of this option shall vest and become exercisable on May 2, 2023, with the remainder vesting in 12 equal quarterly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F3]On May 2, 2022, the reporting person was granted 20,000 restricted stock units, with one-third vesting on May 2, 2023, and the remainder vesting in two equal yearly installments on each of the one-year anniversaries thereafter.